Literature DB >> 26611441

Molecular and pathogenicity characterization of Gallid herpesvirus 2 newly isolated in China from 2009 to 2013.

Yan-Ping Zhang1, Hong-Chao Lv1, Ke-Yan Bao1, Yu-Long Gao1, Hong-Lei Gao1, Xiao- le Qi1, Hong-Yu Cui1, Yong-Qiang Wang1, Kai Li1, Li Gao1, Xiao-Mei Wang2, Chang-Jun Liu3.   

Abstract

During the course of our continuous surveillance of Gallid herpesvirus 2 (GaHV-2), 44 isolates were obtained from GaHV-2-positive chickens of different flocks in China from 2009 to 2013. The meq gene, considered as a major GaHV-2 oncogene, was sequenced and was found to contain an open reading frame of 1020 nucleotides encoding a 339 amino acid (aa) polypeptide in all isolates. Compared with the GaHV-2 GA strain, the meq genes in 15.9 % (7/44) of the isolates analyzed in this study contained an aa substitution mutation at position 88 (A to T) of which is the first report. The main characteristics of Chinese GaHV-2 isolates meq genes included the substitutions K77E, D80Y, V115A, T139A, P176R, and P217A, and the aa substitution frequency at positions 139 and 176 showed an increase. To test the pathogenicity of the isolates, a pathogenicity study and a vaccination-challenge test were performed on three selected isolates (ZY/1203, WC/1203, and WC/1110) and reference strain GA. The results showed that the three isolates induced gross Marek's disease (MD) lesions in 95.0-100 % cases, which was a higher rate than that obtained for strain GA (82.4 %). Three isolates induced mortality in 10-21.1 % of specific-pathogen-free chickens, which was similar to results with strain GA (23.5 %). The commercially available CVI988 vaccine induced lower protective indices (PIs) against ZY/1203 (82.4) and WC/1110 (83.3) as compared to those against WC/1203 (100) and GA (100). These results showed an evolving trend in the meq genes of the isolates; three isolates exhibited higher morbidity as compared to the reference strain and the vaccine induced lower PIs against two isolates as compared to that against the reference strain.

Entities:  

Keywords:  Gallid herpesvirus 2; Molecular characterization; Pathogenicity characterization; meq gene

Mesh:

Substances:

Year:  2015        PMID: 26611441     DOI: 10.1007/s11262-015-1264-z

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  37 in total

1.  Serotype 1 viruses modified by backpassage or insertional mutagenesis: approaching the threshold of vaccine efficacy in Marek's disease.

Authors:  R L Witter; K S Kreager
Journal:  Avian Dis       Date:  2004-12       Impact factor: 1.577

2.  Analysis of transcriptional activities of the Meq proteins present in highly virulent Marek's disease virus strains, RB1B and Md5.

Authors:  Shiro Murata; Tsukasa Okada; Rika Kano; Yuko Hayashi; Tomoyuki Hashiguchi; Misao Onuma; Satoru Konnai; Kazuhiko Ohashi
Journal:  Virus Genes       Date:  2011-04-19       Impact factor: 2.332

3.  Evolution of Marek's disease -- a paradigm for incessant race between the pathogen and the host.

Authors:  Venugopal Nair
Journal:  Vet J       Date:  2005-09       Impact factor: 2.688

4.  The RNA subunit of telomerase is encoded by Marek's disease virus.

Authors:  Laëtitia Fragnet; Maria A Blasco; Wolfram Klapper; Denis Rasschaert
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

5.  Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells.

Authors:  Z Z Cui; L F Lee; J L Liu; H J Kung
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

6.  Vaccination and reduced cohort duration can drive virulence evolution: Marek's disease virus and industrialized agriculture.

Authors:  Katherine E Atkins; Andrew F Read; Nicholas J Savill; Katrin G Renz; A F M Fakhrul Islam; Stephen W Walkden-Brown; Mark E J Woolhouse
Journal:  Evolution       Date:  2012-11-04       Impact factor: 3.694

7.  Novel applications of feather tip extracts from MDV-infected chickens; diagnosis of commercial broilers, whole genome separation by PFGE and synchronic mucosal infection.

Authors:  Irit Davidson; Rinat Borenshtain
Journal:  FEMS Immunol Med Microbiol       Date:  2003-10-15

8.  Comparative analysis of oncogenic genes revealed unique evolutionary features of field Marek's disease virus prevalent in recent years in China.

Authors:  Mingxing Tian; Yang Zhao; Yan Lin; Nianli Zou; Cheng Liu; Ping Liu; Sanjie Cao; Xintian Wen; Yong Huang
Journal:  Virol J       Date:  2011-03-15       Impact factor: 4.099

9.  Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek's disease virus.

Authors:  Andrew C Brown; Susan J Baigent; Lorraine P Smith; Jason P Chattoo; Lawrence J Petherbridge; Pippa Hawes; Martin J Allday; Venugopal Nair
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-30       Impact factor: 11.205

10.  A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis.

Authors:  Sascha Trapp; Mark S Parcells; Jeremy P Kamil; Daniel Schumacher; B Karsten Tischer; Pankaj M Kumar; Venugopal K Nair; Nikolaus Osterrieder
Journal:  J Exp Med       Date:  2006-05-01       Impact factor: 14.307

View more
  2 in total

1.  Co-Infection with Marek's Disease Virus and Reticuloendotheliosis Virus Increases Illness Severity and Reduces Marek's Disease Vaccine Efficacy.

Authors:  Guo-Rong Sun; Yan-Ping Zhang; Lin-Yi Zhou; Hong-Chao Lv; Feng Zhang; Kai Li; Yu-Long Gao; Xiao-Le Qi; Hong-Yu Cui; Yong-Qiang Wang; Li Gao; Qing Pan; Xiao-Mei Wang; Chang-Jun Liu
Journal:  Viruses       Date:  2017-06-21       Impact factor: 5.048

2.  A Chinese Variant Marek's Disease Virus Strain with Divergence between Virulence and Vaccine Resistance.

Authors:  Guo-Rong Sun; Yan-Ping Zhang; Hong-Chao Lv; Lin-Yi Zhou; Hong-Yu Cui; Yu-Long Gao; Xiao-le Qi; Yong-Qiang Wang; Kai Li; Li Gao; Qing Pan; Xiao-Mei Wang; Chang-Jun Liu
Journal:  Viruses       Date:  2017-04-03       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.